Posted on July 28, 2020 by Mike Lauer
It has been four months since the COVID-19 pandemic shuttered laboratories and clinical studies across the country and the world. On April 10, only a few weeks into the pandemic, the Congressional Research Service (CRS) published a report on the “Effects of COVID-19 on the Federal Research and Development Enterprise.” The report described the consequences of social distancing and other pandemic mitigation measures. These consequences included laboratory closures, de-prioritized projects, cancellation of meetings and conferences, loss of revenue, disrupted personnel processes (e.g., graduation, promotion, hiring), supply-chain interruptions, and, overlying all of these, a great deal of uncertainty.
Read more http://shorturl.at/CJMRW